KR101748712B1 - 호흡기 질환의 치료 또는 예방 방법 - Google Patents

호흡기 질환의 치료 또는 예방 방법 Download PDF

Info

Publication number
KR101748712B1
KR101748712B1 KR1020157017530A KR20157017530A KR101748712B1 KR 101748712 B1 KR101748712 B1 KR 101748712B1 KR 1020157017530 A KR1020157017530 A KR 1020157017530A KR 20157017530 A KR20157017530 A KR 20157017530A KR 101748712 B1 KR101748712 B1 KR 101748712B1
Authority
KR
South Korea
Prior art keywords
cells
stro
cell
asthma
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157017530A
Other languages
English (en)
Korean (ko)
Other versions
KR20150090237A (ko
Inventor
실비우 이테스쿠
라비 크리쉬난
피터 고쉬
Original Assignee
메소블라스트, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메소블라스트, 아이엔씨. filed Critical 메소블라스트, 아이엔씨.
Publication of KR20150090237A publication Critical patent/KR20150090237A/ko
Application granted granted Critical
Publication of KR101748712B1 publication Critical patent/KR101748712B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020157017530A 2012-12-12 2013-12-12 호흡기 질환의 치료 또는 예방 방법 Active KR101748712B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Publications (2)

Publication Number Publication Date
KR20150090237A KR20150090237A (ko) 2015-08-05
KR101748712B1 true KR101748712B1 (ko) 2017-06-19

Family

ID=50933587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157017530A Active KR101748712B1 (ko) 2012-12-12 2013-12-12 호흡기 질환의 치료 또는 예방 방법

Country Status (11)

Country Link
US (3) US10028979B2 (https=)
EP (1) EP2931373B1 (https=)
JP (5) JP6313327B2 (https=)
KR (1) KR101748712B1 (https=)
CN (2) CN115919901A (https=)
AU (4) AU2013360026B2 (https=)
CA (1) CA2893951C (https=)
ES (1) ES2759281T3 (https=)
IL (1) IL239309A0 (https=)
SG (2) SG10201807682PA (https=)
WO (1) WO2014089625A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
CA3074470C (en) * 2017-09-15 2024-01-16 Cynata Therapeutics Limited Method for treating allergic airways disease (aad)/ asthma
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
EP1483371B1 (en) * 2002-02-19 2007-06-27 Medipost, Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CA2866468C (en) * 2004-09-24 2019-09-03 Mesoblast, Inc. Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor
WO2006108229A1 (en) * 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
EP3424514B1 (en) * 2007-08-06 2022-05-11 Mesoblast, Inc. Tnap+ mesenchymal precursor cells for use in treating connective tissue diseases
US20100247577A1 (en) * 2007-10-17 2010-09-30 Txcell Tr1 cells, mesenchymal stem cells and uses thereof
CA2735800C (en) * 2008-09-03 2018-05-01 Angioblast Systems, Inc. Expansion of haemopoietic precursors
CA2803641A1 (en) * 2010-07-02 2012-01-05 Mesoblast, Inc. Treatment of t-cell mediated immune disorders
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
WO2012162754A1 (en) * 2011-06-03 2012-12-06 Mesoblast, Inc Methods of treating or preventing neurological diseases
CN115919901A (zh) 2012-12-12 2023-04-07 麦瑟布莱斯特公司 治疗或预防呼吸病症的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Tracey L. Bonfield, et al. Am J Physiol Lung Cell Mol Physiol. Vol.299(6): p.760-770. (2010.09.03. 공개)*

Also Published As

Publication number Publication date
US20190046575A1 (en) 2019-02-14
JP6665218B2 (ja) 2020-03-13
AU2013360026A1 (en) 2015-07-02
KR20150090237A (ko) 2015-08-05
WO2014089625A1 (en) 2014-06-19
CN115919901A (zh) 2023-04-07
HK1210077A1 (en) 2016-04-15
US10028979B2 (en) 2018-07-24
SG10201807682PA (en) 2018-10-30
US20150306146A1 (en) 2015-10-29
CA2893951C (en) 2022-05-03
JP2018118987A (ja) 2018-08-02
AU2020202022A1 (en) 2020-04-09
SG11201504352TA (en) 2015-07-30
AU2022209219B2 (en) 2025-08-14
AU2018226514A1 (en) 2018-09-27
AU2018226514B2 (en) 2020-01-02
EP2931373B1 (en) 2019-08-21
US20200289578A1 (en) 2020-09-17
CA2893951A1 (en) 2014-06-19
JP2016502980A (ja) 2016-02-01
CN105377274A (zh) 2016-03-02
EP2931373A1 (en) 2015-10-21
US10688134B2 (en) 2020-06-23
IL239309A0 (en) 2015-07-30
JP2022065132A (ja) 2022-04-26
AU2013360026B2 (en) 2018-06-21
JP2020097618A (ja) 2020-06-25
JP6313327B2 (ja) 2018-04-18
JP2024041904A (ja) 2024-03-27
EP2931373A4 (en) 2016-05-04
ES2759281T3 (es) 2020-05-08
AU2022209219A1 (en) 2022-08-18
JP7420844B2 (ja) 2024-01-23

Similar Documents

Publication Publication Date Title
JP7420844B2 (ja) 呼吸器系疾患を治療又は予防する方法
JP2023030116A (ja) 内皮機能不全及び炎症の疾患の治療
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation
HK40014520A (en) Treatment of diseases of endothelial dysfunction and inflammation
HK1195488A (en) Methods for treating obesity and/or metabolic syndrome
HK1195488B (en) Methods for treating obesity and/or metabolic syndrome

Legal Events

Date Code Title Description
A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 10